![Dirk L. Sebastian](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dirk L. Sebastian
Nessuna posizione attualmente
Profilo
Dirk L.
Sebastian was the founder of Ganymed Pharmaceuticals AG, where he held the title of Chief Financial & Operating Officer from 2001 to 2009.
He also founded LüneCom Kommunikationslösungen GmbH.
Mr. Sebastian's former job was as a founding member of LüneCom Kommunikationslösungen GmbH.
Mr. Sebastian received his undergraduate degrees from the University of Hamburg and the University of Siegen.
Precedenti posizioni note di Dirk L. Sebastian
Società | Posizione | Fine |
---|---|---|
LüneCom Kommunikationslösungen GmbH
![]() LüneCom Kommunikationslösungen GmbH Major TelecommunicationsCommunications Part of UBS Group AG, LüneCom Kommunikationslösungen GmbH is a German company that provides broadband connection services. The company is based in Lueneburg, Germany. The company was founded in 1995 by Norbert Hill, who has been the CEO since 1995. LüneCom Kommunikationslösungen was acquired by UBS Asset Management AG on August 19, 2021. | Corporate Officer/Principal | - |
Ganymed Pharmaceuticals AG
![]() Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Fondatore | - |
Formazione di Dirk L. Sebastian
University of Hamburg | Undergraduate Degree |
University of Siegen | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Ganymed Pharmaceuticals AG
![]() Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Health Technology |
LüneCom Kommunikationslösungen GmbH
![]() LüneCom Kommunikationslösungen GmbH Major TelecommunicationsCommunications Part of UBS Group AG, LüneCom Kommunikationslösungen GmbH is a German company that provides broadband connection services. The company is based in Lueneburg, Germany. The company was founded in 1995 by Norbert Hill, who has been the CEO since 1995. LüneCom Kommunikationslösungen was acquired by UBS Asset Management AG on August 19, 2021. | Communications |
- Borsa valori
- Insiders
- Dirk L. Sebastian